-
Cantor Raises Price Target For Paratek Pharma, Sees 82% Upside
Friday, June 17, 2016 - 5:08pm | 299Cantor Fitzgerald has raised its price target on the shares of Paratek Pharmaceuticals Inc (NASDAQ: PRTK) to $30 (82 percent upside) from $27 after the company announced positive data from the Phase 3 trial of Omadacycline in acute bacterial skin and skin structure infections (ABSSSI). The...